ENBIOSIS Biotechnology specializes in microbiome-based solutions aimed at enhancing immune health and preventing autoimmune diseases. The company serves a diverse clientele, including individuals seeking to improve their health, healthcare providers, and research institutions. Operating in the biotechnology market, ENBIOSIS leverages advanced scientific research to develop personalized health solutions. The business model revolves around offering diagnostic tests and personalized treatment plans based on microbiome analysis. Revenue is generated through the sale of these diagnostic kits and subscription-based personalized health plans. The company operates globally with offices in the Netherlands, Ukraine, the United Kingdom, and Turkey.

Keywords: microbiome, immune health, autoimmune diseases, biotechnology, personalized health, diagnostic tests, treatment plans, global operations, scientific research, healthcare.